English
简体中文
Total: £ 56.28
Published Date: 2025-12-03 | Pages: 83 | Tables: 87 | Pharma & Healthcare
The global market for Diagnostic Imaging Marker was valued at US$ 1352 million in the year 2024 and is projected to reach a revised size of US$ 2172 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Diagnostic imaging markers are agents or devices designed to enhance the visualization of lesions across medical imaging modalities such as X-ray, CT, MRI, ultrasound, and nuclear medicine. They include contrast media, radiotracers, MRI contrast agents, ultrasound microbubbles, and intraoperative or interventional markers used for lesion localization. Their primary functions are to improve lesion contrast, aid in localization and staging, assess functional and metabolic status, and guide surgical or interventional procedures—directly influencing diagnostic accuracy and therapeutic decision-making. With the rise of molecular imaging, radiomics, and theranostics, imaging markers are evolving from single-purpose contrast enhancers into multifunctional platforms that integrate diagnosis, phenotyping, and treatment-guidance, serving as essential connectors across radiology, oncology, interventional, and surgical care pathways.The average gross profit margin of this product is 65%.
With the continuous improvement of global healthcare and rapid iteration of imaging technologies, the diagnostic imaging marker market has encountered unprecedented development opportunities. The rise of precision medicine and personalized therapy has driven an increasing demand for high-sensitivity and high-specificity imaging markers. At the same time, growing needs for early screening of cancer, cardiovascular, and neurological diseases have prompted healthcare institutions and research centers to invest more in high-quality markers. Furthermore, interdisciplinary technological integration, such as molecular imaging combined with artificial intelligence, provides new application scenarios and value enhancement opportunities for diagnostic imaging markers. Supportive policies and gradually improved regulatory frameworks also offer a solid foundation for healthy industry growth.
Despite significant market potential, the diagnostic imaging marker industry faces multiple challenges. Long R&D cycles, high technical barriers, and stringent clinical validation requirements necessitate substantial investment of capital and resources before new product launches. Meanwhile, significant differences in medical regulatory policies across regions make product approval and market entry complex, increasing compliance risks for companies. Fluctuations in raw material prices, supply chain disruptions, and reliance on a limited number of suppliers for critical technologies can also impact production and profitability. Moreover, as market competition intensifies, companies must continue investing in innovation, brand development, and service support to maintain a competitive edge.
As healthcare institutions increasingly focus on early diagnosis and precision therapy, clinical demand for diagnostic imaging markers is showing steady growth. Hospitals, imaging centers, and research institutions are gradually shifting from generic markers to high-value, customized molecular imaging markers to meet the needs of different disease types and individualized patient care. The reliance of pharmaceutical and research companies on high-sensitivity markers during drug development is also increasing, creating new growth opportunities for the industry. Furthermore, the rising frequency of imaging examinations and the widespread adoption of multi-modal imaging will further drive downstream market expansion.
The production of diagnostic imaging markers relies on high-purity chemical reagents, specific biomolecular carriers, and highly stable fluorescent or radioactive isotopes as key raw materials. The quality and stability of raw materials directly affect the imaging performance and safety of markers, making reliability and traceability critical considerations when selecting supply chain partners. Additionally, raw material pricing and technological innovation capabilities are key factors for cost control and product differentiation. As demand for high-performance markers grows, upstream suppliers are continuously optimizing production processes and improving the purity and functionalization of raw materials, providing robust support for downstream enterprises.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Imaging Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Imaging Marker.
The Diagnostic Imaging Marker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Imaging Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, by Imaging Modality and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Imaging Marker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Lantheus Medical Imaging
Bracco Imaging
Curium Pharma
Jubilant Pharmova
Aurobindo Pharma
Siemens
NTP Radioisotopes
ANSTO
Polatom
China Isotope & Radiation
Yantai Dongcheng
Seed Medical
Segment by Type
Small-Molecule Contrast Agents
Radiotracers
Other
Segment by Imaging Modality
CT Contrast Agents
MRI Contrast Agents
Nuclear Medicine Tracers
Other
Segment by Administration
Intravenous (IV) Administration
Local Injection/Perfusion
Oral Contrast
Segment by Application
Hospital
Image Center
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Imaging Modality etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Imaging Marker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Imaging Marker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small-Molecule Contrast Agents
1.2.3 Radiotracers
1.2.4 Other
1.3 Market by Imaging Modality
1.3.1 Global Diagnostic Imaging Marker Market Size Growth Rate by Imaging Modality: 2020 VS 2024 VS 2031
1.3.2 CT Contrast Agents
1.3.3 MRI Contrast Agents
1.3.4 Nuclear Medicine Tracers
1.3.5 Other
1.4 Market by Administration
1.4.1 Global Diagnostic Imaging Marker Market Size Growth Rate by Administration: 2020 VS 2024 VS 2031
1.4.2 Intravenous (IV) Administration
1.4.3 Local Injection/Perfusion
1.4.4 Oral Contrast
1.5 Market by Application
1.5.1 Global Diagnostic Imaging Marker Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Image Center
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Imaging Marker Market Perspective (2020-2031)
2.2 Global Diagnostic Imaging Marker Growth Trends by Region
2.2.1 Global Diagnostic Imaging Marker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diagnostic Imaging Marker Historic Market Size by Region (2020-2025)
2.2.3 Diagnostic Imaging Marker Forecasted Market Size by Region (2026-2031)
2.3 Diagnostic Imaging Marker Market Dynamics
2.3.1 Diagnostic Imaging Marker Industry Trends
2.3.2 Diagnostic Imaging Marker Market Drivers
2.3.3 Diagnostic Imaging Marker Market Challenges
2.3.4 Diagnostic Imaging Marker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Imaging Marker Players by Revenue
3.1.1 Global Top Diagnostic Imaging Marker Players by Revenue (2020-2025)
3.1.2 Global Diagnostic Imaging Marker Revenue Market Share by Players (2020-2025)
3.2 Global Top Diagnostic Imaging Marker Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diagnostic Imaging Marker Revenue
3.4 Global Diagnostic Imaging Marker Market Concentration Ratio
3.4.1 Global Diagnostic Imaging Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Imaging Marker Revenue in 2024
3.5 Global Key Players of Diagnostic Imaging Marker Head office and Area Served
3.6 Global Key Players of Diagnostic Imaging Marker, Product and Application
3.7 Global Key Players of Diagnostic Imaging Marker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Imaging Marker Breakdown Data by Type
4.1 Global Diagnostic Imaging Marker Historic Market Size by Type (2020-2025)
4.2 Global Diagnostic Imaging Marker Forecasted Market Size by Type (2026-2031)
5 Diagnostic Imaging Marker Breakdown Data by Application
5.1 Global Diagnostic Imaging Marker Historic Market Size by Application (2020-2025)
5.2 Global Diagnostic Imaging Marker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diagnostic Imaging Marker Market Size (2020-2031)
6.2 North America Diagnostic Imaging Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diagnostic Imaging Marker Market Size by Country (2020-2025)
6.4 North America Diagnostic Imaging Marker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Imaging Marker Market Size (2020-2031)
7.2 Europe Diagnostic Imaging Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diagnostic Imaging Marker Market Size by Country (2020-2025)
7.4 Europe Diagnostic Imaging Marker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Imaging Marker Market Size (2020-2031)
8.2 Asia-Pacific Diagnostic Imaging Marker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diagnostic Imaging Marker Market Size by Region (2020-2025)
8.4 Asia-Pacific Diagnostic Imaging Marker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Diagnostic Imaging Marker Market Size (2020-2031)
9.2 Latin America Diagnostic Imaging Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diagnostic Imaging Marker Market Size by Country (2020-2025)
9.4 Latin America Diagnostic Imaging Marker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Imaging Marker Market Size (2020-2031)
10.2 Middle East & Africa Diagnostic Imaging Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diagnostic Imaging Marker Market Size by Country (2020-2025)
10.4 Middle East & Africa Diagnostic Imaging Marker Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Diagnostic Imaging Marker Introduction
11.1.4 Cardinal Health Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Diagnostic Imaging Marker Introduction
11.2.4 GE Healthcare Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Company Details
11.3.2 Lantheus Medical Imaging Business Overview
11.3.3 Lantheus Medical Imaging Diagnostic Imaging Marker Introduction
11.3.4 Lantheus Medical Imaging Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.3.5 Lantheus Medical Imaging Recent Development
11.4 Bracco Imaging
11.4.1 Bracco Imaging Company Details
11.4.2 Bracco Imaging Business Overview
11.4.3 Bracco Imaging Diagnostic Imaging Marker Introduction
11.4.4 Bracco Imaging Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.4.5 Bracco Imaging Recent Development
11.5 Curium Pharma
11.5.1 Curium Pharma Company Details
11.5.2 Curium Pharma Business Overview
11.5.3 Curium Pharma Diagnostic Imaging Marker Introduction
11.5.4 Curium Pharma Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.5.5 Curium Pharma Recent Development
11.6 Jubilant Pharmova
11.6.1 Jubilant Pharmova Company Details
11.6.2 Jubilant Pharmova Business Overview
11.6.3 Jubilant Pharmova Diagnostic Imaging Marker Introduction
11.6.4 Jubilant Pharmova Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.6.5 Jubilant Pharmova Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Diagnostic Imaging Marker Introduction
11.7.4 Aurobindo Pharma Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.7.5 Aurobindo Pharma Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Diagnostic Imaging Marker Introduction
11.8.4 Siemens Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.8.5 Siemens Recent Development
11.9 NTP Radioisotopes
11.9.1 NTP Radioisotopes Company Details
11.9.2 NTP Radioisotopes Business Overview
11.9.3 NTP Radioisotopes Diagnostic Imaging Marker Introduction
11.9.4 NTP Radioisotopes Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.9.5 NTP Radioisotopes Recent Development
11.10 ANSTO
11.10.1 ANSTO Company Details
11.10.2 ANSTO Business Overview
11.10.3 ANSTO Diagnostic Imaging Marker Introduction
11.10.4 ANSTO Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.10.5 ANSTO Recent Development
11.11 Polatom
11.11.1 Polatom Company Details
11.11.2 Polatom Business Overview
11.11.3 Polatom Diagnostic Imaging Marker Introduction
11.11.4 Polatom Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.11.5 Polatom Recent Development
11.12 China Isotope & Radiation
11.12.1 China Isotope & Radiation Company Details
11.12.2 China Isotope & Radiation Business Overview
11.12.3 China Isotope & Radiation Diagnostic Imaging Marker Introduction
11.12.4 China Isotope & Radiation Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.12.5 China Isotope & Radiation Recent Development
11.13 Yantai Dongcheng
11.13.1 Yantai Dongcheng Company Details
11.13.2 Yantai Dongcheng Business Overview
11.13.3 Yantai Dongcheng Diagnostic Imaging Marker Introduction
11.13.4 Yantai Dongcheng Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.13.5 Yantai Dongcheng Recent Development
11.14 Seed Medical
11.14.1 Seed Medical Company Details
11.14.2 Seed Medical Business Overview
11.14.3 Seed Medical Diagnostic Imaging Marker Introduction
11.14.4 Seed Medical Revenue in Diagnostic Imaging Marker Business (2020-2025)
11.14.5 Seed Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diagnostic Imaging Marker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small-Molecule Contrast Agents
Table 3. Key Players of Radiotracers
Table 4. Key Players of Other
Table 5. Global Diagnostic Imaging Marker Market Size Growth Rate by Imaging Modality (US$ Million): 2020 VS 2024 VS 2031
Table 6. Key Players of CT Contrast Agents
Table 7. Key Players of MRI Contrast Agents
Table 8. Key Players of Nuclear Medicine Tracers
Table 9. Key Players of Other
Table 10. Global Diagnostic Imaging Marker Market Size Growth Rate by Administration (US$ Million): 2020 VS 2024 VS 2031
Table 11. Key Players of Intravenous (IV) Administration
Table 12. Key Players of Local Injection/Perfusion
Table 13. Key Players of Oral Contrast
Table 14. Global Diagnostic Imaging Marker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 15. Global Diagnostic Imaging Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Diagnostic Imaging Marker Market Size by Region (2020-2025) & (US$ Million)
Table 17. Global Diagnostic Imaging Marker Market Share by Region (2020-2025)
Table 18. Global Diagnostic Imaging Marker Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 19. Global Diagnostic Imaging Marker Market Share by Region (2026-2031)
Table 20. Diagnostic Imaging Marker Market Trends
Table 21. Diagnostic Imaging Marker Market Drivers
Table 22. Diagnostic Imaging Marker Market Challenges
Table 23. Diagnostic Imaging Marker Market Restraints
Table 24. Global Diagnostic Imaging Marker Revenue by Players (2020-2025) & (US$ Million)
Table 25. Global Diagnostic Imaging Marker Market Share by Players (2020-2025)
Table 26. Global Top Diagnostic Imaging Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Marker as of 2024)
Table 27. Ranking of Global Top Diagnostic Imaging Marker Companies by Revenue (US$ Million) in 2024
Table 28. Global 5 Largest Players Market Share by Diagnostic Imaging Marker Revenue (CR5 and HHI) & (2020-2025)
Table 29. Global Key Players of Diagnostic Imaging Marker, Headquarters and Area Served
Table 30. Global Key Players of Diagnostic Imaging Marker, Product and Application
Table 31. Global Key Players of Diagnostic Imaging Marker, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Diagnostic Imaging Marker Market Size by Type (2020-2025) & (US$ Million)
Table 34. Global Diagnostic Imaging Marker Revenue Market Share by Type (2020-2025)
Table 35. Global Diagnostic Imaging Marker Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 36. Global Diagnostic Imaging Marker Revenue Market Share by Type (2026-2031)
Table 37. Global Diagnostic Imaging Marker Market Size by Application (2020-2025) & (US$ Million)
Table 38. Global Diagnostic Imaging Marker Revenue Market Share by Application (2020-2025)
Table 39. Global Diagnostic Imaging Marker Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 40. Global Diagnostic Imaging Marker Revenue Market Share by Application (2026-2031)
Table 41. North America Diagnostic Imaging Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. North America Diagnostic Imaging Marker Market Size by Country (2020-2025) & (US$ Million)
Table 43. North America Diagnostic Imaging Marker Market Size by Country (2026-2031) & (US$ Million)
Table 44. Europe Diagnostic Imaging Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Europe Diagnostic Imaging Marker Market Size by Country (2020-2025) & (US$ Million)
Table 46. Europe Diagnostic Imaging Marker Market Size by Country (2026-2031) & (US$ Million)
Table 47. Asia-Pacific Diagnostic Imaging Marker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 48. Asia-Pacific Diagnostic Imaging Marker Market Size by Region (2020-2025) & (US$ Million)
Table 49. Asia-Pacific Diagnostic Imaging Marker Market Size by Region (2026-2031) & (US$ Million)
Table 50. Latin America Diagnostic Imaging Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 51. Latin America Diagnostic Imaging Marker Market Size by Country (2020-2025) & (US$ Million)
Table 52. Latin America Diagnostic Imaging Marker Market Size by Country (2026-2031) & (US$ Million)
Table 53. Middle East & Africa Diagnostic Imaging Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Middle East & Africa Diagnostic Imaging Marker Market Size by Country (2020-2025) & (US$ Million)
Table 55. Middle East & Africa Diagnostic Imaging Marker Market Size by Country (2026-2031) & (US$ Million)
Table 56. Cardinal Health Company Details
Table 57. Cardinal Health Business Overview
Table 58. Cardinal Health Diagnostic Imaging Marker Product
Table 59. Cardinal Health Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 60. Cardinal Health Recent Development
Table 61. GE Healthcare Company Details
Table 62. GE Healthcare Business Overview
Table 63. GE Healthcare Diagnostic Imaging Marker Product
Table 64. GE Healthcare Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 65. GE Healthcare Recent Development
Table 66. Lantheus Medical Imaging Company Details
Table 67. Lantheus Medical Imaging Business Overview
Table 68. Lantheus Medical Imaging Diagnostic Imaging Marker Product
Table 69. Lantheus Medical Imaging Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 70. Lantheus Medical Imaging Recent Development
Table 71. Bracco Imaging Company Details
Table 72. Bracco Imaging Business Overview
Table 73. Bracco Imaging Diagnostic Imaging Marker Product
Table 74. Bracco Imaging Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 75. Bracco Imaging Recent Development
Table 76. Curium Pharma Company Details
Table 77. Curium Pharma Business Overview
Table 78. Curium Pharma Diagnostic Imaging Marker Product
Table 79. Curium Pharma Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 80. Curium Pharma Recent Development
Table 81. Jubilant Pharmova Company Details
Table 82. Jubilant Pharmova Business Overview
Table 83. Jubilant Pharmova Diagnostic Imaging Marker Product
Table 84. Jubilant Pharmova Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 85. Jubilant Pharmova Recent Development
Table 86. Aurobindo Pharma Company Details
Table 87. Aurobindo Pharma Business Overview
Table 88. Aurobindo Pharma Diagnostic Imaging Marker Product
Table 89. Aurobindo Pharma Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 90. Aurobindo Pharma Recent Development
Table 91. Siemens Company Details
Table 92. Siemens Business Overview
Table 93. Siemens Diagnostic Imaging Marker Product
Table 94. Siemens Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 95. Siemens Recent Development
Table 96. NTP Radioisotopes Company Details
Table 97. NTP Radioisotopes Business Overview
Table 98. NTP Radioisotopes Diagnostic Imaging Marker Product
Table 99. NTP Radioisotopes Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 100. NTP Radioisotopes Recent Development
Table 101. ANSTO Company Details
Table 102. ANSTO Business Overview
Table 103. ANSTO Diagnostic Imaging Marker Product
Table 104. ANSTO Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 105. ANSTO Recent Development
Table 106. Polatom Company Details
Table 107. Polatom Business Overview
Table 108. Polatom Diagnostic Imaging Marker Product
Table 109. Polatom Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 110. Polatom Recent Development
Table 111. China Isotope & Radiation Company Details
Table 112. China Isotope & Radiation Business Overview
Table 113. China Isotope & Radiation Diagnostic Imaging Marker Product
Table 114. China Isotope & Radiation Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 115. China Isotope & Radiation Recent Development
Table 116. Yantai Dongcheng Company Details
Table 117. Yantai Dongcheng Business Overview
Table 118. Yantai Dongcheng Diagnostic Imaging Marker Product
Table 119. Yantai Dongcheng Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 120. Yantai Dongcheng Recent Development
Table 121. Seed Medical Company Details
Table 122. Seed Medical Business Overview
Table 123. Seed Medical Diagnostic Imaging Marker Product
Table 124. Seed Medical Revenue in Diagnostic Imaging Marker Business (2020-2025) & (US$ Million)
Table 125. Seed Medical Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Diagnostic Imaging Marker Picture
Figure 2. Global Diagnostic Imaging Marker Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diagnostic Imaging Marker Market Share by Type: 2024 VS 2031
Figure 4. Small-Molecule Contrast Agents Features
Figure 5. Radiotracers Features
Figure 6. Other Features
Figure 7. Global Diagnostic Imaging Marker Market Size Comparison by Imaging Modality (2020-2031) & (US$ Million)
Figure 8. CT Contrast Agents Features
Figure 9. MRI Contrast Agents Features
Figure 10. Nuclear Medicine Tracers Features
Figure 11. Other Features
Figure 12. Global Diagnostic Imaging Marker Market Size Comparison by Administration (2020-2031) & (US$ Million)
Figure 13. Intravenous (IV) Administration Features
Figure 14. Local Injection/Perfusion Features
Figure 15. Oral Contrast Features
Figure 16. Global Diagnostic Imaging Marker Market Size by Application (2020-2031) & (US$ Million)
Figure 17. Global Diagnostic Imaging Marker Market Share by Application: 2024 VS 2031
Figure 18. Hospital Case Studies
Figure 19. Image Center Case Studies
Figure 20. Other Case Studies
Figure 21. Diagnostic Imaging Marker Report Years Considered
Figure 22. Global Diagnostic Imaging Marker Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 23. Global Diagnostic Imaging Marker Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 24. Global Diagnostic Imaging Marker Market Share by Region: 2024 VS 2031
Figure 25. Global Diagnostic Imaging Marker Market Share by Players in 2024
Figure 26. Global Diagnostic Imaging Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by Diagnostic Imaging Marker Revenue in 2024
Figure 28. North America Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. North America Diagnostic Imaging Marker Market Share by Country (2020-2031)
Figure 30. United States Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Canada Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Diagnostic Imaging Marker Market Share by Country (2020-2031)
Figure 34. Germany Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. France Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. U.K. Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Italy Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Russia Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Ireland Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Diagnostic Imaging Marker Market Share by Region (2020-2031)
Figure 42. China Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Japan Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. South Korea Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. India Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Australia & New Zealand Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Diagnostic Imaging Marker Market Share by Country (2020-2031)
Figure 50. Mexico Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Brazil Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Diagnostic Imaging Marker Market Share by Country (2020-2031)
Figure 54. Israel Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. UAE Diagnostic Imaging Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Cardinal Health Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 58. GE Healthcare Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 59. Lantheus Medical Imaging Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 60. Bracco Imaging Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 61. Curium Pharma Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 62. Jubilant Pharmova Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 63. Aurobindo Pharma Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 64. Siemens Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 65. NTP Radioisotopes Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 66. ANSTO Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 67. Polatom Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 68. China Isotope & Radiation Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 69. Yantai Dongcheng Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 70. Seed Medical Revenue Growth Rate in Diagnostic Imaging Marker Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
